Top Story

Top Takeaways from ASCO: Prostate cancer screening

Top Takeaways from ASCO: Prostate cancer screening
November 28, 2015

CHICAGO — The revised guidelines for prostate cancer screening with PSA testing issued by the U.S. Preventive Services Task Force in 2012 reduced the number of screenings among men aged 75 years or older, but not in relation to overall rates.

“With the most recent changes in 2012, the U.S. Preventive Services Task Force (USPSTF) essentially recommended against screening any men for prostate cancer with a digital rectal exam or PSA for men of average risk of getting prostate cancer. They gave it a grade D recommendation,” Simon Kim, MD, MPH, assistant professor of urology and urologic oncology at University Hospital Case Medical Center and Case Western Reserve University School of Medicine in Cleveland, Ohio, and a study investigator, told Healio.com. “[There were] two trials that showed really mixed level evidence [regarding screening]. I think the controversy is because one trial showed no benefit and the other did.”

Lurie Comprehensive Cancer Center names associate director

November 28, 2015
Massimo Cristofanilli, MD, has been appointed associate director for precision medicine and translational research at Robert H. Lurie Comprehensive Cancer Center of…
Meeting News Coverage

Top Takeaways from ASCO: Gynecologic cancers and sexual dysfunction

November 27, 2015
Women with gynecologic cancer demonstrated an increased risk for sexual dysfunction, according to results of a multi-institutional, cross-sectional study.Those who were…
In the Journals

Specialized clinics reduce ED visits among adult survivors of pediatric cancer

November 27, 2015
Survivors of childhood cancers who attend specialized survivor clinics for their long-term care into adulthood are less likely to visit a hospital ED than survivors who…
In the Journals

ASCO: Expanded genetic testing should be standard for metastatic colorectal cancer

November 25, 2015
ASCO released a provisional clinical opinion update recommending that all patients with metastatic colorectal cancer who are candidates for anti-EGFR antibody therapy…
More News Headlines »

The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »
Meeting News Coverage Video

HPV vaccination falling short due to providers, not parents

November 22, 2015
More »

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan morganatic-roan